Results 61 to 70 of about 13,238 (197)
Difference in prostate cancer incidence around sixty years: effects of age and metabolic diseases
Cancer Medicine, 2018 We examined the risk of prostate cancer in the Korean population stratified on the basis of age group and risk based on metabolic diseases, using National Health Insurance System (NHIS) data.
Jin Bong Choi +4 more
doaj +1 more source
Managing dyslipidemia in chronic kidney disease: a comprehensive overview of evidence and recommendations [PDF]
The Korean Journal of Internal MedicinePatients with chronic kidney disease (CKD) have a significantly increased risk of developing cardiovascular disease (CVD), making dyslipidemia management a critical component of cardiovascular risk reduction in this population.
Ji Yoon Kim, Suk Min Chung, Nam Hoon Kim
doaj +1 more source
Screening and treatment of pediatric dyslipidemias
, 2014 Guidelines for the screening and management of dyslipidemias in children were published in November 2011 by the National Heart, Lung, and Blood Institute.
Goldwire, Miki
core
, 2021 Purpose of Review: This review aims to summarize the most recent published literature concerning lomitapide and volanesorsen that are approved for the use in HoFH and FCS patients, respectively.
D'Erasmo L., Bini S., Arca M.
core +1 more source
Lipoprotein(a) apheresis restores coronary microcirculation in refractory angina
Revista Portuguesa de Cardiologia, 2022 Francesco Sbrana +5 more
doaj +1 more source
Therapeutic Gene Editing in Dyslipidemias
Reviews in Cardiovascular MedicineDyslipidemia, characterized by abnormal lipid levels in the blood, significantly escalates the risk of atherosclerotic cardiovascular disease and requires effective treatment strategies.
Seyed Saeed Tamehri Zadeh +1 more
doaj +1 more source
Differential lipid metabolism in monocytes and macrophages: influence of cholesterol loading[S]
Journal of Lipid Research, 2016 The influence of the hypercholesterolemia associated with atherosclerosis on monocytes is poorly understood. Monocytes are exposed to high concentrations of lipids, particularly cholesterol and lysophosphatidylcholine (lyso-PC).
Irene Fernandez-Ruiz +4 more
doaj +1 more source
Pharmacotherapy of dyslipidemias in the adult population
, 2010 Importance of the field: Lipid-modifying drugs are therapeutic options that have been shown to reduce the biological and clinical burden related to atherosclerosis; they can be used to correct minor lipid abnormalities, as well as the more severe ...
FELLIN, Renato +3 more
core +1 more source
Análise do perfil lipídico em escolares Lipid profile analysis in school children
Arquivos Brasileiros de Cardiologia, 2007 FUNDAMENTO: A aterosclerose coronariana (DAC) é a maior causa mortis do mundo, segundo a Organização Mundial de Saúde. O estudo INTERHEART mostrou que a dislipidemia é um dos maiores fatores de risco independente para o IAM.
Carlos Scherr +2 more
doaj +1 more source